BioCryst Pharma (BCRX) Posts Q4 Loss of 16c/Share; Updates on Pipeline, FY15 Outlook
Go back to BioCryst Pharma (BCRX) Posts Q4 Loss of 16c/Share; Updates on Pipeline, FY15 Outlook| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 8.76 +0.08 (0.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.68 | 52 Week High | $10.98 | |||
| Open | $8.75 | 52 Week Low | $1.63 | |||
| Day High | $8.85 | P/E | N/A | |||
| Day Low | $8.58 | EPS | $-0.68 | |||
| Volume | 3,462,949 | |||||
